BioLineRx Ltd.

Related Filers (15)

Other (439)

6-K
Friday, 2/16/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 1/5/2024
Notice of Effectiveness
F-3
Friday, 12/29/2023
Registration statement for specified transactions by certain foreign private issuers
6-K
Thursday, 12/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/12/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/30/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/25/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/22/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 3/22/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 3/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/4/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F/A
Friday, 9/9/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 8/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/5/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 3/16/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/24/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/18/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/17/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/18/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/27/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Tuesday, 9/21/2021
Order Granting Confidential Treatment
6-K
Friday, 9/3/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/18/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/26/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 2/24/2021
Notice of Effectiveness
6-K
Tuesday, 2/23/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Tuesday, 2/23/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
POS AM
Tuesday, 2/23/2021
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Friday, 1/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/21/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Monday, 1/11/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Monday, 1/11/2021
Notice of Effectiveness
F-3
Thursday, 12/31/2020
Registration statement for specified transactions by certain foreign private issuers
6-K
Wednesday, 12/16/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/16/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/23/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/18/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/30/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/29/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/25/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/24/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/19/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/19/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Wednesday, 8/12/2020
Notice of Effectiveness
POS AM
Friday, 8/7/2020
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Thursday, 8/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 7/2/2020
Notice of Effectiveness
CORRESP
Wednesday, 7/1/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Friday, 6/26/2020
Registration statement for securities of certain foreign private issuers
D
Wednesday, 6/10/2020
Exempt (Private) Offering
D
Wednesday, 6/10/2020
Exempt (Private) Offering
6-K
Wednesday, 6/3/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/1/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/28/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/27/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/26/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/26/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/20/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Monday, 3/23/2020
Order Granting Confidential Treatment
6-K
Thursday, 3/12/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/12/2020
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/5/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/27/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Wednesday, 2/19/2020
Order Granting Confidential Treatment
6-K
Thursday, 1/30/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/22/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Show More

Ownership (53)

SC 13D
Thursday, 10/26/2023
Hong Seng Technology Ltd: Major Shareholders
SC 13G/A
Friday, 2/11/2022
INTRACOASTAL CAPITAL, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Altium Capital Management LP: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
NOVARTIS PHARMA AG: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Senvest Management, LLC: Major Shareholders
SC 13G/A
Friday, 1/29/2021
INTRACOASTAL CAPITAL, LLC: Major Shareholders
SC 13G/A
Wednesday, 1/6/2021
SABBY MANAGEMENT, LLC: Major Shareholders
SC 13G/A
Tuesday, 11/3/2020
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Friday, 6/5/2020
INTRACOASTAL CAPITAL, LLC: Major Shareholders
SC 13G
Friday, 6/5/2020
ARMISTICE CAPITAL, LLC: Major Shareholders
SC 13G
Friday, 6/5/2020
Altium Capital Management LP: Major Shareholders
SC 13G/A
Tuesday, 6/2/2020
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Tuesday, 5/26/2020
SABBY MANAGEMENT, LLC: Major Shareholders
SC 13G
Friday, 2/14/2020
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G/A
Friday, 2/7/2020
Senvest Management, LLC: Major Shareholders
SC 13D/A
Friday, 3/1/2019
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Friday, 2/8/2019
Senvest Management, LLC: Major Shareholders
SC 13G/A
Friday, 2/8/2019
Senvest Management, LLC: Major Shareholders
SC 13G/A
Monday, 2/12/2018
Senvest Management, LLC: Major Shareholders
SC 13G/A
Thursday, 12/14/2017
NOVARTIS PHARMA AG: Major Shareholders
SC 13D
Tuesday, 8/8/2017
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Monday, 4/10/2017
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13D/A
Wednesday, 3/8/2017
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13G/A
Monday, 2/13/2017
Senvest Management, LLC: Major Shareholders
SC 13G/A
Monday, 2/13/2017
Broadfin Capital, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/16/2016
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
SC 13G/A
Friday, 2/12/2016
Broadfin Capital, LLC: Major Shareholders
SC 13G/A
Friday, 2/12/2016
Senvest Management, LLC: Major Shareholders
SC 13D/A
Tuesday, 6/16/2015
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13G
Monday, 3/16/2015
Broadfin Capital, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/17/2015
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
SC 13G/A
Friday, 1/9/2015
SABBY MANAGEMENT, LLC: Major Shareholders
SC 13G
Wednesday, 1/7/2015
RIMA SENVEST MANAGEMENT, L.L.C.: Major Shareholders
SC 13G
Monday, 12/22/2014
NOVARTIS PHARMA AG: Major Shareholders
SC 13G
Friday, 3/14/2014
SABBY MANAGEMENT, LLC: Major Shareholders
SC 13D/A
Monday, 3/10/2014
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13G/A
Thursday, 2/13/2014
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
SC 13D/A
Friday, 3/8/2013
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13G/A
Tuesday, 2/19/2013
RIMA SENVEST MANAGEMENT, L.L.C.: Major Shareholders
SC 13G
Friday, 2/15/2013
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
SC 13G/A
Thursday, 2/14/2013
RIMA SENVEST MANAGEMENT, L.L.C.: Major Shareholders
SC 13G/A
Thursday, 2/14/2013
Clal Insurance Enterprises Holdings Ltd: Major Shareholders
SC 13D/A
Tuesday, 10/16/2012
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13D/A
Monday, 4/2/2012
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13G
Thursday, 3/29/2012
Migdal Insurance & Financial Holdings Ltd.: Major Shareholders
SC 13G
Tuesday, 3/20/2012
RIMA SENVEST MANAGEMENT, L.L.C.: Major Shareholders
SC 13D/A
Wednesday, 3/7/2012
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13D
Monday, 2/27/2012
FCMI FINANCIAL CORP ET AL: Major Shareholders
SC 13G
Tuesday, 2/14/2012
Major Shareholders
SC 13G
Tuesday, 2/14/2012
Clal Insurance Enterprises Holdings Ltd: Major Shareholders
SC 13G
Tuesday, 2/14/2012
Migdal Insurance & Financial Holdings Ltd.: Major Shareholders
SC 13G
Tuesday, 2/14/2012
TEVA PHARMACEUTICAL INDUSTRIES LTD: Major Shareholders
SC 13G
Tuesday, 2/7/2012
FCMI FINANCIAL CORP ET AL: Major Shareholders
Show More

Prospectus (43)

S-8
Friday, 12/29/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Friday, 1/20/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Tuesday, 9/20/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 9/3/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 1/21/2021
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Wednesday, 1/20/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Tuesday, 1/19/2021
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Tuesday, 1/19/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 12/31/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 11/13/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 9/25/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Thursday, 7/2/2020
Prospectus filed pursuant to Rule 424(b)(3)
424B5
Wednesday, 6/3/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 5/28/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 4/17/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 2/5/2019
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 2/4/2019
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 1/19/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 10/31/2017
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 7/26/2017
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 4/3/2017
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 3/30/2017
Prospectus filed pursuant to Rule 424(b)(5)
S-8 POS
Wednesday, 3/29/2017
Post-effective amendment to a S-8 registration statement
S-8
Tuesday, 1/5/2016
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Monday, 6/8/2015
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Monday, 6/8/2015
Prospectus filed pursuant to Rule 424(b)(3)
424B5
Friday, 3/6/2015
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 3/5/2015
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Wednesday, 12/31/2014
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B2
Friday, 6/13/2014
Prospectus filed pursuant to Rule 424(b)(2)
424B5
Tuesday, 3/4/2014
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 3/3/2014
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 3/3/2014
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Thursday, 8/8/2013
Prospectus filed pursuant to Rule 424(b)(3)
424B5
Friday, 5/17/2013
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 5/17/2013
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 2/6/2013
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Monday, 10/15/2012
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Wednesday, 9/19/2012
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Thursday, 8/2/2012
Prospectus filed pursuant to Rule 424(b)(3)
424B3
Wednesday, 3/28/2012
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Monday, 8/22/2011
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
RW
Friday, 7/1/2011
Registration Withdrawal Request
Show More